AI assistant
Ocugen, Inc. — Director's Dealing 2021
Nov 4, 2021
32915_dirs_2021-11-03_e3556953-d86f-4587-a3f1-a101b8058759.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2021-11-02
Reporting Person: Zhang Junge (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-02 | Common Stock | S | 149700 | $15.75 | Disposed | 881731 | Indirect |
Footnotes
F1: This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.50 to $16.27. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The Reporting Person previously transferred 818,578 shares of common stock held directly by the Reporting Person to the Gupiao Trust in March 2021.